Table 1 showed no differences in age, sex, clinical severity, D-Dimer, procalcitonin, IL-6, ferritin, comorbid hypertension, liver disease, cancer, pulmonary disease, kidney disease, and the number of comorbidities in the obese and non-obese group of patients SARS-CoV-2 (p>0.05). This evidence concerns the gene IL6 and cancer.